Efficacy, Safety and Immunological Evaluation of Tofacitinib in the Treatment of Primary Sjogren's Syndrome

Summary

This study aims to explore the clinical and immunological efficacy of tofacitinib on primary Sjögren's Syndrome

Timeline

Start

2021-11-20

Primary completion

2023-01-01

Completion

2023-10-01

Publications

• Liu Q, Zeng Y, Xing X, Huang B, Feng R, Wang Y, Wang N, Zhang X, Li Y, Su L, Jacob A, Ambrus JL Jr, Shen L, Suresh L, Yu D, Lin X, He J. Evaluating the therapeutic potential of tofacitinib in Sjogren's disease: a comprehensive clinical and immunological assessment. Rheumatology (Oxford). 2025 Nov 1;64(11):5899-5910. doi: 10.1093/rheumatology/keaf173.

Drugs

Indications